Lauren Siebenaler, DNP, NNP-BC, and Deborah Steward, PhD, RN, discuss the subjective nature of identifying the color “bilious” in gastric residuals, explain the impact of the subjectivity of identifying bilious gastric residuals, and review recommendations for developing standardized clinical practice guidelines for assessment and management of feeding intolerance in the NICU.
In this video, Jeffrey Loughead, MD, FAAP, shares his experience from developing a probiotic program and protocol in the NICU.
An infographic that outlines the risk of dysbiosis—the abnormal colonization or the imbalance of microbes—developing in the preterm infant’s immature gut, as well as the role the microbiome can play in promoting better health while lowering the risk for adverse health consequences.
Dr Groh-Wargo discusses the critical steps in preterm infant clinical growth assessment to calculate growth velocity, assess catch-up growth, evaluate growth charts, and monitor for extrauterine growth restriction. She also reviews the new international growth standards for intrauterine growth of preterm infants developed by the INTERGROWTH-21st Project, and Z-scores for monitoring growth trajectories.
This study evaluated the risk and outcomes of SARS-CoV-2 transmission from positive healthcare workers to infants in the NICU and the postnatal ward.
A controlled study with the goal of comparing growth, feeding tolerance, and clinical and biochemical evaluations in human milk-fed preterm infants who received either an acidified or nonacidified liquid human milk fortifier.
Schanler RJ, Groh-Wargo SL, Barrett-Reis B, White RD, Ahmad KA, Oliver J, Baggs G, Williams L, Adamkin D. J Pediatr. 2018;202:31-37.e2.
This ESPGHAN probiotic meta-analysis paper identifies strains with high efficacy and addresses safety issues of probiotic supplementation to preterm infants, who have reduced immunological capacities and occasional indwelling catheters.
van den Akker C, van Goudoever JB, Shamir R, et al. J Pediatr Gastroenterol Nutr. 2020;70(5):664-680. doi:10.1097/MPG.0000000000002655
This study was a comparison of growth and tolerance in premature infants fed either standard powdered human milk fortifier (HMF) or a newly formulated concentrated liquid that contained extensively hydrolyzed protein.
Kim, JH, Chan, G, Schanler, R, Groh-Wargo, S, Bloom, B, Dimmit, R, Williams, L, Baggs, G, & Barrett-Reis, B (2015). Growth and Tolerance of Preterm Infants Fed a New Extensively Hydrolyzed Liquid Human Milk Fortifier. Journal of Pediatric Gastroenterology and Nutrition, 61(6), 665–671. https://doi.org/10.1097/MPG.0000000000001010
An extensive portfolio of science-based nutrition products with clinical results aids nutrition-challenged and very low-birth-weight NICU infants.
A descriptive infographic of a preterm infant's catch-up growth essentials and their benefits.
Flexible, science-based solutions to meet the needs of your patients with customizable solutions for individualized outcomes.
A 22 Cal/fl oz, nutrient-enriched* formula for babies who were born prematurely. Designed to be used as a preterm post-discharge formula.
* Increased protein, vitamins, and minerals compared to term infant formula.
Intended for premature and low-birth-weight infants as a nutritional supplement to add to human milk.
Intended for premature and low-birth-weight infants as a nutritional supplement to add to human milk.
A 20 Cal/fl oz., iron-fortified feeding for growing, low-birth-weight infants and premature infants.
A 24 Cal/fl oz., iron-fortified feeding for growing, low-birth-weight infants and premature infants.
A 24 Cal /fl oz., iron-fortified feeding for growing, low-birth-weight infants and premature infants who may need extra protein to help support growth.
A 30 Cal/fl oz., iron-fortified feeding for growing, low-birth-weight infants and premature infants.
An overview of NeoSure products which are WIC-eligible.
Preparation instructions, visual and written, for mixing Similac NeoSure formula.
References: 1. Evereklian M et. al J Pediatr Nurs. May-Jun 2017;34:e10-e16. doi: 10.1016/j.pedn.2017.02.006. 2. Barfield WD Clin Perinatol. 2018 Sep;45(3):565-577. doi: 10.1016/j.clp.2018.05.007.
Your sample eligibility has been revoked. You are no longer eligible to send samples to patients.
Would you like to submit this sample eligibility approval request to ?
Click “Yes” to confirm.
You are about to decline 's sample eligibility request.
Would you like to approve ’s sample eligibility request? This will be the only eligible user that you can approve to send samples while they are linked to your account.
Click “Yes” to confirm.
Would you like to revoke ’s sample eligibility?
Click “Yes” to confirm.
Would you like to submit this request to revoke your sample eligibility?
Click “Yes” to confirm.
Request has been declined.
Please be aware that the website you have requested to view is intended for Healthcare Professionals and may not be owned or maintained by Abbott. A new window will open in your browser once you select “yes”. You can return to this site by clicking the back arrow.
Do you wish to continue and exit this website?
